Fundamental & Clinical Pharmacology

Adverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tract
pp. 393-403(11)
Author: Langman M.J.S.

Ginkgo biloba extracts and cancer: a research area in its infancy
pp. 405-417(13)
Authors: DeFeudis F.V.; Papadopoulos V.; Drieu K.

Alzheimer's disease: the pharmacological pathway
pp. 419-428(10)
Authors: Allain H.; Bentué-Ferrer D.; Tribut O.; Gauthier S.; Michel B-F.; Rochelle C.D-L.

Extracellular calcium level is crucial for aortic contractile response in pregnant rat
pp. 429-432(4)
Authors: Dièye A.M.; Gairard A.

Effect of two new PBN-derived phosphorylated nitrones against postischaemic ventricular dysrhythmias
pp. 433-442(10)
Authors: Vergely C.; Renard C.; Moreau D.; Perrin- Sarrado C.; Roubaud V.; Tuccio B.; Rochette L.

Effects of glucose–insulin–potassium on baroreflex sensitivity, left ventricular function and ventricular arrhythmia in the subacute phase of myocardial infarction in rats
pp. 443-448(6)
Authors: Liu J-G.; Shu H.; Shen F-M.; Miao C-Y.; Su D-F.

Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test
pp. 449-455(7)
Authors: Renard C.E.; Dailly E.; David D.J.P.; Hascoet M.; Bourin M.

Molecular characterization of the high-affinity [³H]neuropeptide Y-binding component from the venom of Conus anemone
pp. 457-462(6)
Authors: Le M.T.; Vanderheyden P.M.L.; Fierens F.L.P.; Vauquelin G.

MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes
pp. 463-469(7)
Authors: Oselin K.; Gerloff T.; Mrozikiewicz P.M.; Pähkla R.; Roots I.

Extracting numerical data from published reports of pharmacokinetics investigations: method description and validation
pp. 471-472(2)
Authors: Oliveira I.R.; Santos-Jesus R.; Po A.L.W.; Poolsup N.

Pharmacokinetic–pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects
pp. 473-481(9)
Authors: Aymard G.; Berlin I.; de Brettes B.; Diquet B.

The pros and cons of noninferiority trials
pp. 483-490(8)
Author: Pocock S.J.

Lipid-lowering drugs and serum liver enzymes: the effects of body weight and baseline enzyme levels
pp. 491-494(4)
Authors: Kiortsis D.N.; Nikas S.; Hatzidimou K.; Tsianos E.; Elisaf M.S.

How should therapeutic information be transferred to users?
pp. 495-503(9)
Authors: Boissel J-P.; Haugh M.; Fardeheb M.; Nony P.; Gueyffier F.; Strang N.